Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression

Trial Profile

Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Irritable bowel syndrome; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Nov 2016 Results of preliminary analysis published in the Journal of Clinical Psychopharmacology.
    • 23 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 19 Aug 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top